Indian companies Mumbai-headquartered Cipla, Hyderabad-based Hetero Labs and Noida-based Jubilant Life Sciences has signed up the agreement to manufacture the drug and to sell it in 127 countries.
Though India produces 20% of the world’s generic drug supply, pharma companies in the country are dependent on China for two-thirds of the chemical components needed to make them.
Indian Medical Association (IMA) president K K Aggarwal has welcomed the government’s move to reduce prices of stents and mandate…
Prime Minister Narendra Modi on Monday indicated that his government may bring in a legal framework under which doctors will have…
